Perindopril erbumine and Sandostatin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Perindopril erbumine (perindopril erbumine) and Sandostatin (octreotide acetate). Common drug interactions include abdominal pain lower among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Perindopril erbumine and Sandostatin. It is created by eHealthMe based on reports of 68 people who take the same drugs from the FDA, and is updated regularly.

What is Perindopril erbumine?

Perindopril erbumine has active ingredients of perindopril erbumine. It is often used in high blood pressure. eHealthMe is studying from 8,958 Perindopril erbumine users. Check the latest studies of Perindopril erbumine.

What is Sandostatin?

Sandostatin has active ingredients of octreotide acetate. It is often used in acromegaly. eHealthMe is studying from 46,793 Sandostatin users. Check the latest studies of Sandostatin.

On Jul, 31, 2026

68 people who take Perindopril erbumine and Sandostatin together, and have interactions are studied.

Perindopril erbumine and Sandostatin drug interactions.

What are the common drug interactions of Perindopril Erbumine and Sandostatin, by gender? *:

female:

Abdominal pain lower
Abdominal pain
Acne (skin problems that cause pimples)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Fibromyalgia (a long-term condition which causes pain all over the body)
Neck pain
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Parotitis (inflammation of a parotid gland)
Rash

male:

Diarrhoea
Pain
Weight decreased
Asthenia (weakness)
Arthralgia (joint pain)
Oedema peripheral (superficial swelling)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Dizziness
Gait disturbance

What are the common drug interactions of Perindopril Erbumine and Sandostatin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Abdominal distension
Bowel movement irregularity
Nausea (feeling of having an urge to vomit)
Pain
Flatulence (flatus expelled through the anus)
Heart rate decreased
Stress
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Arthralgia (joint pain)
Body temperature decreased

60+:

Peripheral swelling
Blood pressure systolic increased
Asthenia (weakness)
Gait disturbance
Joint swelling
Blood pressure decreased
Pain in extremity
Fatigue (feeling of tiredness)
Back pain
Injection site reaction

What are the existing conditions these people have? *

Neuroendocrine Tumor: 28 people, 41.18%
Blood Pressure Systolic Increased: 8 people, 11.76%
Depression: 6 people, 8.82%
Constipation: 6 people, 8.82%
Carcinoid Tumor Of The Small Bowel: 6 people, 8.82%
Vipoma (endocrine tumour): 5 people, 7.35%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 5 people, 7.35%
High Blood Cholesterol: 4 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Perindopril erbumine and Sandostatin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously